| Revision as of 10:03, 24 February 2005 editXezbeth (talk | contribs)Autopatrolled, Administrators282,562 editsmNo edit summary← Previous edit | Revision as of 04:44, 2 March 2005 edit undoCeyockey (talk | contribs)Administrators83,217 editsmNo edit summaryNext edit → | ||
| Line 6: | Line 6: | ||
| ==External links== | ==External links== | ||
| * | * | ||
| ⚫ | {{ |
||
| {{chem-stub}} | |||
| ] | ] | ||
| ⚫ | {{treatment-stub}} | ||
Revision as of 04:44, 2 March 2005
Duloxetine hydrochloride (brand name: Cymbalta) is a medically used drug that primarily targets major depressive disorders (MDD) and stress urinary incontinence (SUI). Known also as LY248686, chemically (+)-(S)-N-methyl-3-(1-naphthyloxy)-2-thiophenepropanamine, it is a potent dual inhibitor of serotonin (5-hydroxytryptamine, 5-HT) and norepinephrine (NE) reuptake, possessing comparable affinities in binding to NE and 5-HT transport sites. Interestingly, its behavior contrasts to most other dual-reuptake inhibitors.
Furthermore, duloxentine lacks affinity for monoamine receptors within the central nervous system. While there is limited data available regarding the pharmacokinetic profile of duloxetine in humans, its half-life is reported to be 10 to 15 hours.
External links
 | This medical treatment–related article is a stub. You can help Misplaced Pages by expanding it. |